2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
出版年份 2016 全文链接
标题
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
作者
关键词
-
出版物
EUROPEAN JOURNAL OF HEART FAILURE
Volume 19, Issue 1, Pages 9-42
出版商
Wiley
发表日期
2016-08-27
DOI
10.1002/ejhf.654
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Risk Assessment and Prophylaxis for VTE in Cancer Patients
- (2017) Alok A. Khorana Journal of the National Comprehensive Cancer Network
- Approach to the Management of Incidental Venous Thromboembolic Events in Patients With Cancer
- (2017) Casey L. O’Connell et al. Journal of the National Comprehensive Cancer Network
- Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
- (2016) Geeta Gulati et al. EUROPEAN HEART JOURNAL
- Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children’s Oncology Group Randomized Trial Pediatric Oncology Group 9404
- (2016) Barbara L. Asselin et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial
- (2016) Pooja P. Advani et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma
- (2016) Frederika A. van Nimwegen et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial
- (2016) Martine Piccart-Gebhart et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapy-Induced Pulmonary Hypertension
- (2015) Benoît Ranchoux et al. AMERICAN JOURNAL OF PATHOLOGY
- Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer
- (2015) Anthony F. Yu et al. BREAST CANCER RESEARCH AND TREATMENT
- Cardiac complications in childhood cancer survivors treated with anthracyclines
- (2015) Vivian I. Franco et al. CARDIOLOGY IN THE YOUNG
- Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
- (2015) D. Cardinale et al. CIRCULATION
- Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors
- (2015) Pooja Ghatalia et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Cancer Chemotherapy and Cardiac Arrhythmias: A Review
- (2015) Juan Tamargo et al. DRUG SAFETY
- 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
- (2015) Silvia G. Priori et al. EUROPEAN HEART JOURNAL
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- (2015) Marco Roffi et al. EUROPEAN HEART JOURNAL
- 2015 ESC Guidelines for the diagnosis and management of pericardial diseases
- (2015) Yehuda Adler et al. EUROPEAN HEART JOURNAL
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
- (2015) Nazzareno Galiè et al. EUROPEAN HEART JOURNAL
- Cardiac assessment of early breast cancer patients 18years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy
- (2015) Evandro de Azambuja et al. EUROPEAN JOURNAL OF CANCER
- Pixantrone: a novel anthracycline-like drug for the treatment of non-Hodgkin lymphoma
- (2015) Eileen Mary Boyle et al. Expert Opinion On Drug Safety
- Cardiovascular disease in Adult Life after Childhood Cancer in Scandinavia: A population-based cohort study of 32,308 one-year survivors
- (2015) Thorgerdur Gudmundsdottir et al. INTERNATIONAL JOURNAL OF CANCER
- Feasibility and Cardiac Safety of Trastuzumab Emtansine After Anthracycline-Based Chemotherapy As (neo)Adjuvant Therapy for Human Epidermal Growth Factor Receptor 2–Positive Early-Stage Breast Cancer
- (2015) Ian E. Krop et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevalence of Cerebral Small-Vessel Disease in Long-Term Breast Cancer Survivors Exposed to Both Adjuvant Radiotherapy and Chemotherapy
- (2015) Vincent Koppelmans et al. JOURNAL OF CLINICAL ONCOLOGY
- Update on Metastatic Gastric and Esophageal Cancers
- (2015) Manish A. Shah JOURNAL OF CLINICAL ONCOLOGY
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
- (2015) Gary H. Lyman et al. JOURNAL OF CLINICAL ONCOLOGY
- Individual Prediction of Heart Failure Among Childhood Cancer Survivors
- (2015) Eric J. Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- Tyrosine Kinase Inhibitor–Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia
- (2015) Javid J. Moslehi et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive Echocardiographic Detection of Treatment-Related Cardiac Dysfunction in Adult Survivors of Childhood Cancer
- (2015) Gregory T. Armstrong et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Health of Patients With Cancer and Cancer Survivors
- (2015) Ana Barac et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Burgeoning Cardio-Oncology Programs
- (2015) Tochi M. Okwuosa et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
- (2015) Roberto M. Lang et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma
- (2015) David J. Cutter et al. JNCI-Journal of the National Cancer Institute
- Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
- (2015) Saro H Armenian et al. LANCET ONCOLOGY
- Erratum: Cardiotoxicity of anticancer treatments
- (2015) Michael S. Ewer et al. Nature Reviews Cardiology
- Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
- (2015) A. Keith Stewart et al. NEW ENGLAND JOURNAL OF MEDICINE
- The UK HeartSpare Study (Stage IB): Randomised comparison of a voluntary breath-hold technique and prone radiotherapy after breast conserving surgery
- (2015) Frederick R. Bartlett et al. RADIOTHERAPY AND ONCOLOGY
- Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer
- (2015) Samuel Z. Goldhaber et al. THROMBOSIS AND HAEMOSTASIS
- EACVI/HFA Cardiac Oncology Toxicity Registry in breast cancer patients: rationale, study design, and methodology (EACVI/HFA COT Registry)--EURObservational Research Program of the European Society of Cardiology
- (2015) P. Lancellotti et al. European Heart Journal-Cardiovascular Imaging
- Cardiovascular Disease After Hodgkin Lymphoma Treatment
- (2015) Frederika A. van Nimwegen et al. JAMA Internal Medicine
- Risk for Valvular Heart Disease After Treatment for Hodgkin Lymphoma
- (2015) David J. Cutter et al. JNCI-Journal of the National Cancer Institute
- Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk
- (2014) C. Lestuzzi et al. ANNALS OF ONCOLOGY
- Vascular safety issues in CML patients treated with BCR/ABL1 kinase inhibitors
- (2014) P. Valent et al. BLOOD
- Congestive heart failure risk in cancer patients treated with vascular endothelial growth factor tyrosine kinase inhibitors: a systematic review and meta-analysis of 36 clinical trials
- (2014) Wei-Xiang Qi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Chemotherapy-Induced Cardiotoxicity: Detection, Prevention, and Management
- (2014) Judy Truong et al. CANADIAN JOURNAL OF CARDIOLOGY
- 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
- (2014) EUROPEAN HEART JOURNAL
- 2014 ESC/EACTS Guidelines on myocardial revascularization
- (2014) EUROPEAN HEART JOURNAL
- Cardiovascular events among 1090 cancer patients treated with sunitinib, interferon, or placebo: A comprehensive adjudicated database analysis demonstrating clinically meaningful reversibility of cardiac events
- (2014) Michael S. Ewer et al. EUROPEAN JOURNAL OF CANCER
- Protective effects of spironolactone against anthracycline-induced cardiomyopathy
- (2014) Mahmut Akpek et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cancer Therapy-Induced Left Ventricular Dysfunction: Interventions and Prognosis
- (2014) Akanksha Thakur et al. JOURNAL OF CARDIAC FAILURE
- Trastuzumab-Associated Cardiac Events at 8 Years of Median Follow-Up in the Herceptin Adjuvant Trial (BIG 1-01)
- (2014) Evandro de Azambuja et al. JOURNAL OF CLINICAL ONCOLOGY
- Exercise and Risk of Major Cardiovascular Events in Adult Survivors of Childhood Hodgkin Lymphoma: A Report From the Childhood Cancer Survivor Study
- (2014) Lee W. Jones et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma
- (2014) S. Limat et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Use of Myocardial Strain Imaging by Echocardiography for the Early Detection of Cardiotoxicity in Patients During and After Cancer Chemotherapy
- (2014) Paaladinesh Thavendiranathan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prevention of Anthracycline-Induced Cardiotoxicity
- (2014) Pimprapa Vejpongsa et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
- (2014) Edward B Garon et al. LANCET
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology
- (2014) Joerg Herrmann et al. MAYO CLINIC PROCEEDINGS
- Non-Vitamin K Antagonist Oral Anticoagulants and the Treatment of Venous Thromboembolism in Cancer Patients: A Semi Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes
- (2014) Torben Bjerregaard Larsen et al. PLoS One
- Therapy for Cancer-Related Thromboembolism
- (2014) Corinne Frere et al. SEMINARS IN ONCOLOGY
- Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
- (2014) J. C. Plana et al. European Heart Journal-Cardiovascular Imaging
- Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging
- (2014) J.-U. Voigt et al. European Heart Journal-Cardiovascular Imaging
- Risk Prediction Model for Heart Failure and Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer
- (2014) Ghideon Ezaz et al. Journal of the American Heart Association
- New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients
- (2014) Grigoris Gerotziafas et al. Therapeutics and Clinical Risk Management
- A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity
- (2014) Anne Polk et al. BMC Pharmacology & Toxicology
- Imatinib in Pulmonary Arterial Hypertension: C-Kit Inhibition
- (2014) Samar Farha et al. Pulmonary Circulation
- Lack of Evidence to Support Thromboprophylaxis in Hospitalized Medical Patients with Cancer
- (2013) Marc Carrier et al. AMERICAN JOURNAL OF MEDICINE
- Trastuzumab therapy in Australia: Which patients with HER2+ metastatic breast cancer are assessed for cardiac function?
- (2013) Christine Y. Lu et al. BREAST
- Incidence and risk of hypertension with a novel multi-targeted kinase inhibitor axitinib in cancer patients: a systematic review and meta-analysis
- (2013) Wei-Xiang Qi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cardiac toxicity in cancer survivors
- (2013) Daniel J. Lenihan et al. CANCER
- Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors
- (2013) Anne Polk et al. CANCER TREATMENT REVIEWS
- Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension
- (2013) Marius M. Hoeper et al. CIRCULATION
- Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
- (2013) Steven E. Lipshultz et al. CIRCULATION
- Cardiac MRI in the Assessment of Cardiac Injury and Toxicity From Cancer Chemotherapy
- (2013) Paaladinesh Thavendiranathan et al. Circulation-Cardiovascular Imaging
- Cardioprotective Effect of β-Adrenoceptor Blockade in Patients With Breast Cancer Undergoing Chemotherapy
- (2013) Sinziana Seicean et al. Circulation-Heart Failure
- Frequency of Severe Valvular Disease Caused by Mediastinal Radiation Among Patients Undergoing Valve Surgery in a Community-Based, Regional Academic Medical Center
- (2013) Kevin A. Copeland et al. CLINICAL CARDIOLOGY
- Clinical Features of Radiation-induced Carotid Atherosclerosis
- (2013) D.M. Gujral et al. CLINICAL ONCOLOGY
- Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on Cardiac Repolarisation (QT Interval)
- (2013) Rashmi R. Shah et al. DRUG SAFETY
- 2013 ESH/ESC Guidelines for the management of arterial hypertension
- (2013) EUROPEAN HEART JOURNAL
- 2013 ESC guidelines on the management of stable coronary artery disease
- (2013) EUROPEAN HEART JOURNAL
- Cardiovascular complications of radiation therapy for thoracic malignancies: the role for non-invasive imaging for detection of cardiovascular disease
- (2013) J. D. Groarke et al. EUROPEAN HEART JOURNAL
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
- (2013) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Risk of hypertension with regorafenib in cancer patients: a systematic review and meta-analysis
- (2013) Zexing Wang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Arterial hypertension and cancer
- (2013) Alberto Milan et al. INTERNATIONAL JOURNAL OF CANCER
- Cardioncology: State of the heart
- (2013) Maria Chiara Todaro et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association of Fibrosis With Mortality and Sudden Cardiac Death in Patients With Nonischemic Dilated Cardiomyopathy
- (2013) Ankur Gulati et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Natriuretic Peptide–Based Screening and Collaborative Care for Heart Failure
- (2013) Mark Ledwidge et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Thromboses itératives de pontages artériels et cancer : à propos de trois cas
- (2013) B. Villemur et al. JOURNAL DES MALADIES VASCULAIRES
- Endothelial Damage in Long-Term Survivors of Childhood Cancer
- (2013) Cornelia A.J. Brouwer et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased Tricuspid Regurgitant Jet Velocity by Doppler Echocardiography in Adult Survivors of Childhood Cancer: A Report From the St Jude Lifetime Cohort Study
- (2013) Gregory T. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology Statement: Achieving High-Quality Cancer Survivorship Care
- (2013) Mary S. McCabe et al. JOURNAL OF CLINICAL ONCOLOGY
- Modifiable Risk Factors and Major Cardiac Events Among Adult Survivors of Childhood Cancer
- (2013) Gregory T. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- Dosimetric and clinical advantages of deep inspiration breath-hold (DIBH) during radiotherapy of breast cancer
- (2013) Vicente Bruzzaniti et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Risk of hypertension in cancer patients treated with sorafenib: an updated systematic review and meta-analysis
- (2013) T Funakoshi et al. JOURNAL OF HUMAN HYPERTENSION
- Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively
- (2013) Ronald G. Schwartz et al. JOURNAL OF NUCLEAR CARDIOLOGY
- Cardiac Complications of Thoracic Irradiation
- (2013) Catherine Jaworski et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies
- (2013) Xavier Bosch et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2013) Clyde W. Yancy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Insights Into Onco-Cardiology
- (2013) Dimitrios Farmakis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab
- (2013) Bonnie Ky et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Independent and Incremental Value of Deformation Indices for Prediction of Trastuzumab-Induced Cardiotoxicity
- (2013) Kazuaki Negishi et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial
- (2013) Aron Goldhirsch et al. LANCET
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial
- (2013) David Cameron et al. LANCET ONCOLOGY
- Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial
- (2013) Robert J Motzer et al. LANCET ONCOLOGY
- Proteotoxicity and Cardiac Dysfunction — Alzheimer's Disease of the Heart?
- (2013) Monte S. Willis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
- (2013) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer-Drug Discovery and Cardiovascular Surveillance
- (2013) John D. Groarke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
- (2013) Sarah C. Darby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overview and Management of Cardiac Adverse Events Associated With Tyrosine Kinase Inhibitors
- (2013) D. J. Lenihan et al. ONCOLOGIST
- Cardio-Oncology: It Takes Two to Translate
- (2013) J. Moslehi et al. Science Translational Medicine
- High incidence of venous thromboembolism despite electronic alerts for thromboprophylaxis in hospitalised cancer patients
- (2013) Margarita Marqués et al. THROMBOSIS AND HAEMOSTASIS
- Low to Moderate Dose Anthracycline-Based Chemotherapy Is Associated With Early Noninvasive Imaging Evidence of Subclinical Cardiovascular Disease
- (2013) Brandon C. Drafts et al. JACC-Cardiovascular Imaging
- Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection
- (2013) K. Negishi et al. European Heart Journal-Cardiovascular Imaging
- Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography
- (2013) P. Lancellotti et al. European Heart Journal-Cardiovascular Imaging
- The Frequency and Severity of Cardiovascular Toxicity From Targeted Therapy in Advanced Renal Cell Carcinoma Patients
- (2013) Philip S. Hall et al. JACC-Heart Failure
- Chemotherapy during pregnancy: effect of anthracyclines on fetal and maternal cardiac function
- (2012) MINA MHALLEM GZIRI et al. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
- Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors
- (2012) Richard M. Steingart et al. AMERICAN HEART JOURNAL
- Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines
- (2012) G. Curigliano et al. ANNALS OF ONCOLOGY
- Incidence and risk of hypertension with vandetanib in cancer patients: a systematic review and meta-analysis of clinical trials
- (2012) Wei-Xiang Qi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cardiac Toxicity of Targeted Therapies Used in the Treatment for Solid Tumours: A Review
- (2012) Marek Svoboda et al. Cardiovascular Toxicology
- Cancer Therapy–Induced Cardiac Toxicity in Early Breast Cancer
- (2012) Michel G. Khouri et al. CIRCULATION
- Pulmonary Arterial Hypertension in Patients Treated by Dasatinib
- (2012) David Montani et al. CIRCULATION
- Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
- (2012) Heloisa Sawaya et al. Circulation-Cardiovascular Imaging
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
- (2012) et al. EUROPEAN HEART JOURNAL
- Cancer drugs and the heart: importance and management
- (2012) T. M. Suter et al. EUROPEAN HEART JOURNAL
- Guidelines on the management of valvular heart disease (version 2012)
- (2012) et al. EUROPEAN HEART JOURNAL
- ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- (2012) et al. EUROPEAN HEART JOURNAL
- Cardiotoxicity of a non-pegylated liposomal doxorubicin-based regimen versus an epirubicin-based regimen for breast cancer: The LITE (Liposomal doxorubicin–Investigational chemotherapy–Tissue doppler imaging Evaluation) randomized pilot study
- (2012) Marzia Lotrionte et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study
- (2012) Mehmet G. Kaya et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Late Cardiac Effects of Cancer Treatment
- (2012) Daniel J. Lenihan et al. JOURNAL OF CLINICAL ONCOLOGY
- Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2012) Edward H. Romond et al. JOURNAL OF CLINICAL ONCOLOGY
- Screening Adult Survivors of Childhood Cancer for Cardiomyopathy: Comparison of Echocardiography and Cardiac Magnetic Resonance Imaging
- (2012) Gregory T. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Statin Therapy on the Risk for Incident Heart Failure in Patients With Breast Cancer Receiving Anthracycline Chemotherapy
- (2012) Sinziana Seicean et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reproducibility of Echocardiographic Techniques for Sequential Assessment of Left Ventricular Ejection Fraction and Volumes
- (2012) Paaladinesh Thavendiranathan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
- (2012) E. J. A. Bowles et al. JNCI-Journal of the National Cancer Institute
- International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
- (2012) D. FARGE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial
- (2012) John R Mackey et al. LANCET ONCOLOGY
- Cardiac Safety of Lapatinib: Pooled Analysis of 3689 Patients Enrolled in Clinical Trials
- (2012) Edith A. Perez et al. MAYO CLINIC PROCEEDINGS
- Dosimetric investigation of accelerated partial breast irradiation (APBI) using CyberKnife
- (2012) Qianyi Xu et al. MEDICAL PHYSICS
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- ERBB2 Inhibition and Heart Failure
- (2012) Gregory M. Cote et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of chemotherapy during pregnancy on the maternal and fetal heart
- (2012) Mina Mhallem Gziri et al. PRENATAL DIAGNOSIS
- Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial
- (2012) Myra F. Barginear et al. SUPPORTIVE CARE IN CANCER
- Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors
- (2011) C. Serrano et al. ANNALS OF ONCOLOGY
- Pooled analysis of cardiac safety in patients with cancer treated with pertuzumab
- (2011) D. Lenihan et al. ANNALS OF ONCOLOGY
- Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101 - Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRI
- (2011) Edith Pituskin et al. BMC CANCER
- Modulation of Anthracycline-Induced Cardiotoxicity by Aerobic Exercise in Breast Cancer
- (2011) Jessica M. Scott et al. CIRCULATION
- An Algorithm for the Management of Hypertension in the Setting of Vascular Endothelial Growth Factor Signaling Inhibition
- (2011) M. Sitki Copur et al. Clinical Colorectal Cancer
- ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries * The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)
- (2011) et al. EUROPEAN HEART JOURNAL
- High Incidence of Thromboembolic Events in Patients Treated With Cisplatin-Based Chemotherapy: A Large Retrospective Analysis
- (2011) Russell A. Moore et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Trastuzumab in HER2-Positive Breast Cancer
- (2011) Dennis Slamon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden
- (2011) Paul McGale et al. RADIOTHERAPY AND ONCOLOGY
- Ischemic Stroke and Transient Ischemic Attack After Head and Neck Radiotherapy
- (2011) Chris Plummer et al. STROKE
- Stenting Versus Surgery in Patients With Carotid Stenosis After Previous Cervical Radiation Therapy
- (2011) Margriet Fokkema et al. STROKE
- Biomarker Approach to the Detection and Cardioprotective Strategies During Anthracycline Chemotherapy
- (2011) Bonnie Ky et al. Heart Failure Clinics
- Increased Risk of High-Grade Hypertension With Bevacizumab in Cancer Patients: A Meta-Analysis
- (2010) V. Ranpura et al. AMERICAN JOURNAL OF HYPERTENSION
- Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper
- (2010) M. Aapro et al. ANNALS OF ONCOLOGY
- Breast Cancer During Pregnancy
- (2010) Elyce Cardonick et al. CANCER JOURNAL
- Cardiovascular effects of systemic cancer treatment
- (2010) Elżbieta Senkus et al. CANCER TREATMENT REVIEWS
- Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
- (2010) Thomas Eschenhagen et al. EUROPEAN JOURNAL OF HEART FAILURE
- Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model
- (2010) K. Van Calsteren et al. GYNECOLOGIC ONCOLOGY
- Cardiac side-effects of cancer chemotherapy
- (2010) Jean-Jacques Monsuez et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Radiation Dose–Volume Effects in the Heart
- (2010) Giovanna Gagliardi et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Cardiac Magnetic Resonance Imaging Findings in 20-year Survivors of Mediastinal Radiotherapy for Hodgkin's Disease
- (2010) Wolfram Machann et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Cardiovascular Risk Factors and Morbidity in Long-Term Survivors of Testicular Cancer: A 20-Year Follow-Up Study
- (2010) Hege S. Haugnes et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of Cancer Treatment in Long-Term Overall and Cardiovascular Mortality After Childhood Cancer
- (2010) Markhaba Tukenova et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
- (2010) Daniela Cardinale et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of Arterial Thromboembolic Events With Sunitinib and Sorafenib: A Systematic Review and Meta-Analysis of Clinical Trials
- (2010) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- Left Ventricular Dysfunction in Patients Receiving Cardiotoxic Cancer Therapies
- (2010) Geoffrey J. Yoon et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anthracycline-Induced Cardiomyopathy
- (2010) Daniela Cardinale et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors
- (2010) Michael L. Maitland et al. JNCI-Journal of the National Cancer Institute
- The metabolic syndrome in cancer survivors
- (2010) Esther C de Haas et al. LANCET ONCOLOGY
- Cardiotoxicity of anticancer treatments: what the cardiologist needs to know
- (2010) Michael S. Ewer et al. Nature Reviews Cardiology
- COMPARISON OF DOXORUBICIN CARDIOTOXICITY IN PEDIATRIC SARCOMA PATIENTS WHEN GIVEN WITH DEXRAZOXANE VERSUS AS CONTINUOUS INFUSION
- (2010) Winston W. Huh et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Cardiac Toxicity From Systemic Cancer Therapy: A Comprehensive Review
- (2010) Giuseppe Curigliano et al. PROGRESS IN CARDIOVASCULAR DISEASES
- The Compelling Need for a Cardiology and Oncology Partnership and the Birth of the International CardiOncology Society
- (2010) Daniel J. Lenihan et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Role of Biomarkers in Chemotherapy-Induced Cardiotoxicity
- (2010) Daniela Cardinale et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Mechanisms of Anthracycline Cardiac Injury: Can We Identify Strategies for Cardioprotection?
- (2010) Douglas B. Sawyer et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Arterial thrombosis in ambulatory cancer patients treated with chemotherapy
- (2010) Marcello Di Nisio et al. THROMBOSIS RESEARCH
- Management of hypertension in angiogenesis inhibitor-treated patients
- (2009) H. Izzedine et al. ANNALS OF ONCOLOGY
- Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring
- (2009) A L Jones et al. BRITISH JOURNAL OF CANCER
- A woman's heart
- (2009) Michael S. Ewer et al. CANCER
- Adjuvant Trastuzumab Induces Ventricular Remodeling Despite Aerobic Exercise Training
- (2009) M. J. Haykowsky et al. CLINICAL CANCER RESEARCH
- Fluoropyrimidine-associated cardiotoxicity: revisited
- (2009) M Wasif Saif et al. Expert Opinion On Drug Safety
- Vascular Endothelial Growth Factor Receptor 2 Controls Blood Pressure by Regulating Nitric Oxide Synthase Expression
- (2009) Carie S. Facemire et al. HYPERTENSION
- Sorafenib-induced acute myocardial infarction due to coronary artery spasm
- (2009) Yuichiro Arima et al. Journal of Cardiology
- Pegylated Liposomal Doxorubicin Plus Docetaxel Significantly Improves Time to Progression Without Additive Cardiotoxicity Compared With Docetaxel Monotherapy in Patients With Advanced Breast Cancer Previously Treated With Neoadjuvant-Adjuvant Anthracycline Therapy: Results From a Randomized Phase III Study
- (2009) Joseph A. Sparano et al. JOURNAL OF CLINICAL ONCOLOGY
- Chronic Disease in the Childhood Cancer Survivor Study Cohort: A Review of Published Findings
- (2009) Lisa Diller et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessing Risk of Venous Thromboembolism in the Patient With Cancer
- (2009) Alok A. Khorana et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer During Pregnancy: An Analysis of 215 Patients Emphasizing the Obstetrical and the Neonatal Outcomes
- (2009) Kristel Van Calsteren et al. JOURNAL OF CLINICAL ONCOLOGY
- Australian Association for Exercise and Sport Science position stand: Optimising cancer outcomes through exercise
- (2009) Sandra C. Hayes et al. JOURNAL OF SCIENCE AND MEDICINE IN SPORT
- Cardiovascular Complications of Cancer Therapy
- (2009) Edward T.H. Yeh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Radiotherapy-Induced Mitral Stenosis: A Three-Dimensional Perspective
- (2009) Mihaela Malanca et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- Increased Risk of Stroke and Transient Ischemic Attack in 5-Year Survivors of Hodgkin Lymphoma
- (2009) Marie L. De Bruin et al. JNCI-Journal of the National Cancer Institute
- Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
- (2009) Adriana Albini et al. JNCI-Journal of the National Cancer Institute
- Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study
- (2009) Giancarlo Agnelli et al. LANCET ONCOLOGY
- Minimizing Cardiotoxicity While Optimizing Treatment Efficacy with Trastuzumab: Review and Expert Recommendations
- (2009) M. Martin et al. ONCOLOGIST
- Cardiac toxicity with anti-HER-2 therapies-what have we learned so far?
- (2009) Evandro de Azambuja et al. Targeted Oncology
- Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: Systematic review and meta-analysis
- (2008) Xiaolei Zhu et al. ACTA ONCOLOGICA
- Radiation-induced peripheral artery disease
- (2008) Javier A. Jurado et al. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
- Mechanisms of Cardiac Dysfunction Associated With Tyrosine Kinase Inhibitor Cancer Therapeutics
- (2008) Ming Hui Chen et al. CIRCULATION
- Cardiotoxicity Profile of Trastuzumab
- (2008) Steven M Ewer et al. DRUG SAFETY
- Appraising cardiotoxicity associated with liposomal doxorubicin by means of tissue Doppler echocardiography end-points
- (2008) Marzia Lotrionte et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Absence of Secondary Malignant Neoplasms in Children With High-Risk Acute Lymphoblastic Leukemia Treated With Dexrazoxane
- (2008) Elly V. Barry et al. JOURNAL OF CLINICAL ONCOLOGY
- Left Ventricular Ejection Fraction and Cardiotoxicity: Is Our Ear Really to the Ground?
- (2008) Michael S. Ewer et al. JOURNAL OF CLINICAL ONCOLOGY
- Doxorubicin, Cardiac Risk Factors, and Cardiac Toxicity in Elderly Patients With Diffuse B-Cell Non-Hodgkin's Lymphoma
- (2008) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
- (2008) Martee L. Hensley et al. JOURNAL OF CLINICAL ONCOLOGY
- New Insight Into Epirubicin Cardiac Toxicity: Competing Risks Analysis of 1097 Breast Cancer Patients
- (2008) Marianne Ryberg et al. JNCI-Journal of the National Cancer Institute
- Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis
- (2008) Shenhong Wu et al. LANCET ONCOLOGY
- VEGF Inhibition and Renal Thrombotic Microangiopathy
- (2008) Vera Eremina et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now